Literature DB >> 31986059

Survey of equal contributions in biomedical research publications.

David B Resnik1, Elise Smith1, Zubin Master2, Min Shi1.   

Abstract

We conducted a cross-sectional survey of 1,540 researchers concerning their experiences with and attitudes toward the ethics of equal contribution (EC) designations in publications. Over half the respondents (58.3%) said they had been designated as an EC at least once. Although most respondents agreed that EC designations can be a useful way of promoting collaborations (81.7%) or resolving disagreements about authorship order (63.3%), a substantial proportion of respondents (38.1%) regarded these designations as useful but ethically questionable. 31.7% of respondents said EC designations are ethically questionable because ECs are difficult to define or measure and 25.9% said they are ethically questionable because people rarely contribute equally. Most respondents (71.8%) agreed that it is unfair to name two people as ECs when they have not contributed equally and that journals (73.4%), research teams (69.5%), and research institutions (63%) should develop policies concerning EC designations. Views concerning the ethics and policies of EC designations were influenced by the race/ethnicity and position of respondents but not by gender. Researchers who had been designated as ECs were less likely to regard this practice as ethically questionable than those who had not.

Entities:  

Keywords:  Authorship; equal contribution; ethics; journals; policy

Mesh:

Year:  2020        PMID: 31986059      PMCID: PMC7065943          DOI: 10.1080/08989621.2020.1722947

Source DB:  PubMed          Journal:  Account Res        ISSN: 0898-9621            Impact factor:   2.622


  24 in total

1.  Cash incentives for papers go global.

Authors:  Alison Abritis; Alison McCook
Journal:  Science       Date:  2017-08-11       Impact factor: 47.728

2.  Best Practice to Order Authors in Multi/Interdisciplinary Health Sciences Research Publications.

Authors:  Elise Smith; Zubin Master
Journal:  Account Res       Date:  2017-01-27       Impact factor: 2.622

3.  Multiple First Authors as Equal Contributors: Is It Ethical?

Authors:  Govindasamy Agoramoorthy
Journal:  Sci Eng Ethics       Date:  2016-06-27       Impact factor: 3.525

4.  A Theoretical Foundation for the Ethical Distribution of Authorship in Multidisciplinary Publications.

Authors:  Elise Smith
Journal:  Kennedy Inst Ethics J       Date:  2017

5.  Misconduct and Misbehavior Related to Authorship Disagreements in Collaborative Science.

Authors:  Elise Smith; Bryn Williams-Jones; Zubin Master; Vincent Larivière; Cassidy R Sugimoto; Adèle Paul-Hus; Min Shi; David B Resnik
Journal:  Sci Eng Ethics       Date:  2019-06-03       Impact factor: 3.525

6.  Collaborative patterns, authorship practices and scientific success in biomedical research: a network analysis.

Authors:  Vanash M Patel; Pietro Panzarasa; Hutan Ashrafian; Tim S Evans; Ali Kirresh; Nick Sevdalis; Ara Darzi; Thanos Athanasiou
Journal:  J R Soc Med       Date:  2019-06       Impact factor: 5.344

7.  Equal contributions and credit: an emerging trend in the characterization of authorship in major anaesthesia journals during a 10-yr period.

Authors:  Zhi Li; Yu-Ming Sun; Fei-Xiang Wu; Li-Qun Yang; Zhi-Jie Lu; Wei-Feng Yu
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

8.  The rise of the middle author: Investigating collaboration and division of labor in biomedical research using partial alphabetical authorship.

Authors:  Philippe Mongeon; Elise Smith; Bruno Joyal; Vincent Larivière
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

9.  Resolving authorship disputes by mediation and arbitration.

Authors:  Zen Faulkes
Journal:  Res Integr Peer Rev       Date:  2018-11-16

10.  Intellectual contributions meriting authorship: Survey results from the top cited authors across all science categories.

Authors:  Gregory S Patience; Federico Galli; Paul A Patience; Daria C Boffito
Journal:  PLoS One       Date:  2019-01-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.